Medicine and Dentistry
Neoplasm
100%
Endometrium Carcinoma
50%
Diseases
45%
Sentinel Lymph Node
42%
Serous Carcinoma
36%
Carcinoma
34%
Pelvis
33%
Overall Survival
30%
Recurrent Disease
27%
Immunohistochemistry
27%
Endometrium
26%
Cervical Cancer
21%
Retroperitoneal Lymph Node Dissection
21%
Uterine Cancer
21%
Peritoneum
20%
Metastatic Carcinoma
20%
Vulva
20%
Fallopian Tube
19%
Lymph Node
18%
Hysterectomy
18%
Endodermal Sinus Tumor
17%
Cancer
17%
Uterine Cervix
16%
Adenocarcinoma
16%
Peritoneum Mesothelioma
16%
Diagnosis
15%
Lymph Duct
15%
Radiation Therapy
15%
Connective Tissue Cancer
15%
Endometriosis
14%
Surgery
14%
Salpingooophorectomy
13%
Female Genital Tract Cancer
13%
Differential Diagnosis
13%
Biopsy Technique
12%
Aggression
12%
Clear Cell Carcinoma
12%
In Situ Hybridization
12%
Paraaortic Lymph Node
11%
Sentinel Lymph Node Biopsy
11%
Sentinel Node
11%
Pathologist
11%
Lymph Node Metastasis
10%
Neuroendocrine Carcinoma
10%
Cervix
10%
Germ Cell
10%
Mesothelioma
10%
Omentum
9%
Somatics
9%
Malignant Neoplasm
9%
Keyphrases
Tumor
37%
Sentinel Lymph Node
30%
Clinicopathologic Study
27%
Endometrial Carcinoma
26%
Sentinel Lymph Node Mapping
21%
Ultrastaging
20%
Carcinoma
15%
Immunohistochemistry
14%
Salpingo-oophorectomy
13%
Yolk Sac Tumor
13%
Gynecological Cancer
13%
Fallopian Tube
13%
Endometrial Cancer
13%
Peritoneum
12%
Sentinel Lymph Node Biopsy
12%
Vulva
11%
Hysterectomy
11%
Uterine Cervix
11%
Pathological Examination
10%
Extragonadal Yolk Sac Tumor
10%
Uterine Carcinosarcoma
10%
Chemotherapy Response Score
10%
Malignant Peritoneal Mesothelioma
10%
Clear Cell Carcinoma
10%
Overall Survival
10%
Lymph Node Metastasis
9%
Lymph Node
9%
Endometriosis
9%
Gynecologic Malignancies
9%
Lymphovascular Invasion
9%
High-grade Serous Carcinoma
9%
Metastasis
8%
Pathologist
8%
Germ Cells
8%
Serous Carcinoma
7%
Germ Cell Tumor
7%
Lymph Node Ratio
7%
Chemotherapy
7%
Lymphadenectomy
7%
Microcystic
7%
Ovarian Carcinoma
7%
Mesonephric-like
6%
Cervical Carcinoma
6%
Primary Surgery
6%
Mucinous Adenocarcinoma
6%
Vaginal Cancer
6%
Single Institution
6%
High-risk Human Papillomavirus (HR-HPV)
6%
Radiation Therapy
6%
Uterus
6%